-
Chinese scientists have spent a decade discovering the "secret" of baby fish
Time of Update: 2021-03-09
"This has created a difficult situation for the protection of large geishans in China, which makes it difficult to see wild populations in the wild, but there are thousands of individuals in the farm, " said Qian Jing, a researcher at the Kunming Animal Institute of the Chinese Academy of Sciences.
-
End a decade of "drug shortage"! Targeting treatment for stomach cancer or ushering in new breakthroughs
Time of Update: 2021-03-05
Results were updated in more than heavyweight studies, with the new drug Bemarituzumab becoming one of the hot topics discussed at this conference, and bemarituzumab's combined chemotherapy first-line treatment FGFR2b over-expression gastric cancer achieved a double improvement in progress-free survival (PFS) and total survival (OS) in the simple chemotherapy group, bringing hope for targeted treatment of stomach cancer in the dark.
-
Interview | What should we focus on in the next decade of new health care reform?
Time of Update: 2021-03-03
Fu Wei: The establishment of the Health Insurance Bureau is a very important thing, changed the original situation of the decentralized functions related to health insurance, more highlighted the impact of the health insurance system on the entire national health and medical services, and in recent years in the health insurance system at the top of the design of a lot of breakthroughs, the health insurance system overall planning, overall management has a relatively large promotion.
-
The first new bone marrow fibrosis drug in nearly a decade! Hundred-time Meishi Shiguibao JAK2
Time of Update: 2021-02-27
It is worth noting that Inrebic is the first new treatment for bone marrow fibrosis in Europe in nearly 10 years, and will also be the first daily oral therapy to significantly reduce spleen volume and symptom burden in patients with ruxolitinib treatment failure, inability to treat ruxolitinib or jak inhibitor primary treatment.
-
Pharmaceutical stocks have led the gains in the past decade and have recently bucked the trend again
Time of Update: 2021-02-17
zhang Xia, an analyst at China Merchants Securities, also said that the pharmaceutical and biological industry has maintained a double-up in revenue and earnings since 2015, the business climate continues to rise, the industry itself has a high defensive nature and performance assurance, is the main line of investment worthy of attention.
-
Novardo Promacta, the first new drug in a decade, has been approved as a first-line therapy
Time of Update: 2021-02-14
Novarca has announced that the U.S. Food and Drug Administration (FDA) has expanded Promacta's adaptation labeling application to support the drug's use in connection with standard immunosuppressive therapy (IST) for first-line treatment in adults with regenerative anemia and pediatric patients 2 years and older.
-
WHO: The number of cancer cases is expected to increase significantly in the coming decades
Time of Update: 2021-02-11
The Number of new cancer cases is expected to increase significantly in the coming decades, with the number of new cases worldwide expected to increase by nearly 50% by 2040 compared with 2020, with low- and middle-income countries seeing the largest increase, the World Health Organization said.
-
A list of 15 policies that have helped China promote doctors to the market over the past decade
Time of Update: 2021-02-04
2018 is the year of the outbreak of China's doctors' group industry, the number of doctors' group's business registration ushered in a new round of peak, the number of doctors group has exceeded a tho
-
Three decades after the fall of China's real paint?
Time of Update: 2021-02-02
years, three trees concentrated resources, the development of the domestic market, in the field of decoration paint to launch the industry-leading health plus series of high-end products, in the engineering paint to form a imitation stone coating as the core of the full range of products and services system.
-
Has there been no new option for first-line treatment of stomach cancer for more than a decade?
Time of Update: 2021-01-22
Said Prime said it would conduct a global Phase 3 clinical trial to further test the efficacy of this combination of first-line treatments for FGFR2b-positive gastric cancer patients.
-
The development of the psychopic drug ketamine, which has been on the market for decades, is still on the way!
Time of Update: 2021-01-21
Among the many drugs on the market, it is worth mentioning the variety, when (Ace) ketamine, after decades of clinical use, finally in 2019 through the improvement of dosage forms and officially turned to the field of antidepressants, and become the world's only fast-acting antidepressants, causing widespread concern in the industry!
-
Pretending to be a doctor and holding a corpse for a price: Why have black ambulances been inundated for decades?
Time of Update: 2021-01-18
In 2010, after successful heart surgery at Tongji Hospital in Wuhan, Zhang Huagang was ready to transfer back to his hometown to continue treatment. Doctors in particular to account for the family,
-
The development of the psychopic drug ketamine, which has been on the market for decades, is still on the way!
Time of Update: 2021-01-09
Among the many drugs on the market, it is worth mentioning the variety, when (Ace) ketamine, after decades of clinical use, finally in 2019 through the improvement of dosage forms and officially turned to the field of antidepressants, and become the world's only fast-acting antidepressants, causing widespread concern in the industry!
-
Head and neck cancer has ushered in a new breakthrough in treatment that has not been expected in a decade
Time of Update: 2020-12-28
On December 11th, the official website of China's State Drug Administration (NMPA) showed that the Merca East PD-1 inhibitor Paboliju monoanti (commodity name: Corida) had been approved for use in assessing tumor expression PD through fully validated testing -L1 (comprehensive positive score (CPS)≥20) metastatic or non-removable relapsed head and neck squamous cell carcinoma (HNSCC) patients first-line treatment, became the first immune first-line treatment of head and neck squamous cancer.
-
The first new bone marrow fibrosis drug in nearly a decade! Hundred-time Meishi Shiguibao JAK2
Time of Update: 2020-12-27
December 15, 2020 / -- BMS recently announced that the European Medicines Agency (EMA) Committee on Human Pharmaceutical Products (CHMP) has issued a positive review recommending approval of the high